Perritt Capital Management Inc Chroma Dex Corp. Transaction History
Perritt Capital Management Inc
- $185 Million
- Q3 2024
A detailed history of Perritt Capital Management Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Perritt Capital Management Inc holds 40,000 shares of CDXC stock, worth $210,799. This represents 0.08% of its overall portfolio holdings.
Number of Shares
40,000
Previous 40,000
-0.0%
Holding current value
$210,799
Previous $109,000
33.94%
% of portfolio
0.08%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
95Shares Held
17.2MCall Options Held
66.7KPut Options Held
8.2K-
Vanguard Group Inc Valley Forge, PA3.43MShares$18.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$16.4 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.96MShares$15.6 Million5.59% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$6.83 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.06 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $360M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...